Current Public Notices Published: 22 July, 2026 Published: 22 July, 2026 Published: 21 July, 2026 Published: 20 July, 2026 Published: 20 July, 2026 Published: 15 July, 2026 Published: 13 July, 2026 Published: 13 July, 2026 Published: 6 July, 2026 Published: 1 July, 2026 Published: 16 June, 2026 Current Legal Analysis More from Keller and Heckman LLP Upcoming Events Aug 11 2026 Sep 14-16 2026 Sep 17-18 2026 Sep 17-18 2026
The combination can significantly reduce appetite and caloric intake, which, if not carefully managed, may lead to dehydration, fatigue, or low blood pressure particularly in individuals also taking antihypertensive medications
This medication contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone released when you eat
N-methyl-glycine, also called sarcosine, which has been shown to accumulate in prostate neoplastic cells acting as an apoptotic inhibitor [51] and as an epigenetic modifier [52], thus representing a potential biomarker for the diagnosis of this cancer in the early stage [53]
Vanuytsel T, Tack J, Farre R
